SANDOZ AMPHETAMINE XR DIN 02457342
Status: Cancelled Post Market
Holder: SANDOZ CANADA INCORPORATED
Molecule: MIXED SALTS AMPHETAMINE
Available to quote
Health Canada record
| Active ingredient(s) | MIXED SALTS AMPHETAMINE 30 MG |
|---|---|
| Dosage form | Capsule (Extended-Release) |
| Route | Oral |
| Schedule | CONTROLLED DRUGS (CDSA I) |
| Class | Human |
| ATC | N06BA01 AMFETAMINE |
| Original market date | 22-Dec-2016 |
| Current status date | 31-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MIXED SALTS AMPHETAMINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02248808 | ADDERALL XR | TAKEDA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 5 MG | Marketed |
| 02248809 | ADDERALL XR | TAKEDA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 10 MG | Marketed |
| 02248810 | ADDERALL XR | TAKEDA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 15 MG | Marketed |
| 02248811 | ADDERALL XR | TAKEDA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 20 MG | Marketed |
| 02248812 | ADDERALL XR | TAKEDA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 25 MG | Marketed |
| 02248813 | ADDERALL XR | TAKEDA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 30 MG | Marketed |
| 02445506 | APO-AMPHETAMINE XR | APOTEX INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 10 MG | Marketed |
| 02445549 | APO-AMPHETAMINE XR | APOTEX INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 30 MG | Marketed |
| 02445530 | APO-AMPHETAMINE XR | APOTEX INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 25 MG | Marketed |
| 02445522 | APO-AMPHETAMINE XR | APOTEX INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 20 MG | Marketed |
| 02445514 | APO-AMPHETAMINE XR | APOTEX INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 15 MG | Marketed |
| 02445492 | APO-AMPHETAMINE XR | APOTEX INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 5 MG | Marketed |
| 02513935 | TARO-AMPHETAMINE XR | SUN PHARMA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 30 MG | Approved |
| 02513889 | TARO-AMPHETAMINE XR | SUN PHARMA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 5 MG | Approved |
| 02513897 | TARO-AMPHETAMINE XR | SUN PHARMA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 10 MG | Approved |
| 02513900 | TARO-AMPHETAMINE XR | SUN PHARMA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 15 MG | Approved |
| 02513919 | TARO-AMPHETAMINE XR | SUN PHARMA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 20 MG | Approved |
| 02513927 | TARO-AMPHETAMINE XR | SUN PHARMA CANADA INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 25 MG | Approved |
| 02439239 | TEVA-AMPHETAMINE XR | TEVA CANADA LIMITED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 5 MG | Marketed |
| 02439298 | TEVA-AMPHETAMINE XR | TEVA CANADA LIMITED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 30 MG | Marketed |
| 02439271 | TEVA-AMPHETAMINE XR | TEVA CANADA LIMITED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 25 MG | Marketed |
| 02439263 | TEVA-AMPHETAMINE XR | TEVA CANADA LIMITED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 20 MG | Marketed |
| 02439255 | TEVA-AMPHETAMINE XR | TEVA CANADA LIMITED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 15 MG | Marketed |
| 02439247 | TEVA-AMPHETAMINE XR | TEVA CANADA LIMITED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 10 MG | Marketed |
| 02440369 | PMS-AMPHETAMINES XR | PHARMASCIENCE INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 5 MG | Dormant |
| 02440377 | PMS-AMPHETAMINES XR | PHARMASCIENCE INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 10 MG | Dormant |
| 02440385 | PMS-AMPHETAMINES XR | PHARMASCIENCE INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 15 MG | Dormant |
| 02440393 | PMS-AMPHETAMINES XR | PHARMASCIENCE INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 20 MG | Dormant |
| 02440407 | PMS-AMPHETAMINES XR | PHARMASCIENCE INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 25 MG | Dormant |
| 02440415 | PMS-AMPHETAMINES XR | PHARMASCIENCE INC | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 30 MG | Dormant |
| 02457296 | SANDOZ AMPHETAMINE XR | SANDOZ CANADA INCORPORATED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 10 MG | Cancelled Post Market |
| 02457318 | SANDOZ AMPHETAMINE XR | SANDOZ CANADA INCORPORATED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 15 MG | Cancelled Post Market |
| 02457326 | SANDOZ AMPHETAMINE XR | SANDOZ CANADA INCORPORATED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 20 MG | Cancelled Post Market |
| 02457334 | SANDOZ AMPHETAMINE XR | SANDOZ CANADA INCORPORATED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 25 MG | Cancelled Post Market |
| 02457288 | SANDOZ AMPHETAMINE XR | SANDOZ CANADA INCORPORATED | Capsule (Extended-Release) | MIXED SALTS AMPHETAMINE 5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 18494 | 2016-09-20 | New Drug Submission (NDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |